Soluble CD160 augments cytokine secretion and cytolytic activity by tumor-specific CD8-T cells in vitro

被引：0
|
作者：
Xiao, H. [1 ]
Sun, H. [1 ]
Xiang, F. [1 ]
Xia, Q. [1 ]
Liu, X. [1 ]
Xiang, Y. [1 ]
机构：
[1] Wuhan Med & Hlth Ctr Women & Children, Lab Med, Wuhan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
354P
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [1] CD160 Activation by Herpesvirus Entry Mediator Augments Inflammatory Cytokine Production and Cytolytic Function by NK Cells
    Sedy, John R.
    Bjordahl, Ryan L.
    Bekiaris, Vasileios
    Macauley, Matthew G.
    Ware, Brian C.
    Norris, Paula S.
    Lurain, Nell S.
    Benedict, Chris A.
    Ware, Carl F.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (02): : 828 - 836
  • [2] CD160 is essential for the development of memory CD8+ T cells
    Zhang, L.
    Zhu, X.
    He, Q.
    Qiu, C.
    Zhu, L.
    Zhao, C.
    Ye, L.
    Fu, Y.
    Zhang, X.
    Xu, J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 366 - 367
  • [3] Differential and tumor-specific expression of CD160 in B-cell malignancies
    Farren, Timothy W.
    Giustiniani, Jerome
    Liu, Feng-Ting
    Tsitsikas, Dimitris A.
    Macey, Marion G.
    Cavenagh, James D.
    Oakervee, Heather E.
    Taussig, David
    Newland, Adrian C.
    Calaminici, Maria
    Bensussan, Armand
    Jenner, Michael
    Gribben, John G.
    Agrawal, Samir G.
    BLOOD, 2011, 118 (08) : 2174 - 2183
  • [4] Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
    Church, Sarah E.
    Jensen, Shawn M.
    Antony, Paul A.
    Restifo, Nicholas P.
    Fox, Bernard A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (01) : 69 - 79
  • [5] Molecular profiling of tumor-specific cytolytic CD4 T cells in human cancer
    Cenerenti, M.
    Saillard, M.
    Liu, Y. C.
    Li, X.
    Cachot, A.
    Rockinger, G. A.
    Matter, R.
    Guillaume, P.
    Schmidt, J.
    Harari, A.
    Trapani, J.
    Speiser, D.
    Jeker, L.
    Romero, P.
    Altug, H.
    Jandus, C.
    SWISS MEDICAL WEEKLY, 2021, 151 : 11S - 11S
  • [6] Molecular profiling of tumor-specific cytolytic CD4 T cells in human cancer
    Cenerenti, M.
    Saillard, M.
    Matter, R.
    Liu, Y. C.
    Li, X.
    Altug, H.
    Speiser, D.
    Jeker, L.
    Romero, P.
    Jandus, C.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 9 - 9
  • [7] IN-VITRO EXPANSION OF TUMOR-SPECIFIC, HLA-RESTRICTED HUMAN CD8(+) CYTOLYTIC T-LYMPHOCYTES
    NAKASHIMA, M
    WATANABE, T
    KOPROWSKI, H
    SCHUCHTER, L
    STEPLEWSKI, Z
    CELLULAR IMMUNOLOGY, 1994, 155 (01) : 53 - 61
  • [8] Differential Suppression of Tumor-Specific CD8+ T Cells by Regulatory T Cells
    James, Edward
    Yeh, Alex
    King, Cathy
    Korangy, Firouzeh
    Bailey, Ian
    Boulanger, Denise S.
    Van den Eynde, Benoit J.
    Murray, Nicholas
    Elliott, Tim J.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (09): : 5048 - 5055
  • [9] Identification of tumor-specific CD8 T cells with a surface marker
    Becht, Etienne
    Newell, Evan W.
    Simoni, Yannick
    M S-MEDECINE SCIENCES, 2018, 34 (12): : 1032 - 1034
  • [10] Tumor-specific cytolytic CD4 T cells mediate immunity against human cancer
    Cachot, Amelie
    Bilous, Mariia
    Liu, Yen-Cheng
    Li, Xiaokang
    Saillard, Margaux
    Cenerenti, Mara
    Rockinger, Georg Alexander
    Wyss, Tania
    Guillaume, Philippe
    Schmidt, Julien
    Genolet, Raphael
    Ercolano, Giuseppe
    Protti, Maria Pia
    Reith, Walter
    Ioannidou, Kalliopi
    de Leval, Laurence
    Trapani, Joseph A.
    Coukos, George
    Harari, Alexandre
    Speiser, Daniel E.
    Mathis, Alexander
    Gfeller, David
    Altug, Hatice
    Romero, Pedro
    Jandus, Camilla
    SCIENCE ADVANCES, 2021, 7 (09):
12345